Clinical Trial Update: Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life [Phase 2]

View source ↗

Summary

Phase 2 study assessing the efficacy, safety, and quality of life outcomes of combining simultaneous integrated boost radiotherapy (SIB-IMRT) with 5-FU and mito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Cancer

Drugs mentioned

• 5-FU (5-fluorouracil)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Locally Advanced Anal Canal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING